Griseofulvin Suspension
Product Images NDC 0713-0850

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Griseofulvin (NDC 0713-0850). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cosette Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula Of Griseofulvin (Griseofulvin 1)

Structural Formula Of Griseofulvin (Griseofulvin 1)
Chemical structure diagram of Griseofulvin showing its molecular formula C17H17ClO6 and molecular weight 352.77.*
FDA Label Image

The Label For 4 Fl Oz Griseofulvin Oral Suspension, Usp (microsize) 125 mg/5 mL (Griseofulvin 2)

The Label For 4 Fl Oz Griseofulvin Oral Suspension, Usp (microsize) 125 mg/5 mL (Griseofulvin 2)
Label for Griseofulvin Oral Suspension, USP (Microsize) 125 mg/5 mL, an oral suspension with 0.2% alcohol. The label indicates a package size of 4 fluid ounces (118 mL) produced by Cosette Pharmaceuticals, Inc. It includes dosage information and storage instructions on the label.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.